(2R,3R,4S,5R)-2-(4,5-dimethylpyrrolo[2',3':4,5]pyrrolo[2,3-d]pyrimidin-8(5H)-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

Catalog No. :
ACBKNR297
CAS No. :
2180983-44-0
Molecular Formula :
C15H18N4O4
Molecular Weight :
318.33

IUPAC Name:(2R,3R,4S,5R)-2-(4,5-dimethylpyrrolo[2',3':4,5]pyrrolo[2,3-d]pyrimidin-8(5H)-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

(2R,3R,4S,5R)-2-(4,5-dimethylpyrrolo[2',3':4,5]pyrrolo[2,3-d]pyrimidin-8(5H)-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3R,4S,5R)-2-(4,5-dimethylpyrrolo[2',3':4,5]pyrrolo[2,3-d]pyrimidin-8(5H)-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
IUPAC Name(2R,3R,4S,5R)-2-(4,5-dimethylpyrrolo[2',3':4,5]pyrrolo[2,3-d]pyrimidin-8(5H)-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
Molecular FormulaC15H18N4O4
Molecular Weight318.33
SMILESCC1=C2C3=C(C=CN3C)N([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C2=NC=N1
InChI KeyFFIKXEFPABQZHN-QGMIFYJMSA-N
SynonymPyrrolo[2',3':4,5]pyrrolo[2,3-d]pyrimidine, 5,8-dihydro-4,5-dimethyl-8-β-D-ribofuranosyl-;(2R,3R,4S,5R)-2-{3,12-dimethyl-3,7,9,11-tetraazatricyclo[6.4.0.02,?]dodeca-1(12),2(6),4,8,10-pentaen-7-yl}-5-(hydroxymethyl)oxolane-3,4-diol;4,5-dimethyl-8-(β-D-ribofuranosyl)-5,8-dihydropyrrolo[2',3':4,5]pyrrolo[2,3-d]pyrimidine
CAS No.2180983-44-0

Synthetic Route by SureRoute

1. ACBKNR297 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBKNR297 route product structure diagram
    ACBKNR2972180983-44-0
Inquiry

2. ACBKNR297 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBKNR297 route product structure diagram
    ACBKNR2972180983-44-0
Inquiry

Comments (0)